You have a lot of negative news coming out. It is a possibility that Walgreens is not getting their customers back from the Script deal. The stock is overvalued and needs to get a haircut in my opinion only.
Problems are two-fold. 1) Express Scripts and other PBMs have excluded WAG from many preferred networks, which are becoming a large part of PBMs' total business mix. So even if the PBM contracts with WAG, it doesn't mean that WAG has access to all or even most of the PBM's members. This was largely self-inflicted by WAG as they essentially proved that Express Scripts would be just fine without them. The fact that leadership was not fired over this bonehead move led me to sell all my WAG stock.
2) WAG is paying a $25 bonus for patients who transfer scripts to WAG. This will help slow top-line bleeding, but the expenses associated with this could add tremendous costs and am not convinced that it will be a net positive investment over time.